Coghill, David R. http://orcid.org/0000-0003-3017-9737
Banaschewski, Tobias
Bliss, Caleb
Robertson, Brigitte
Zuddas, Alessandro http://orcid.org/0000-0002-4409-0680
Article History
First Online: 30 January 2018
Compliance with Ethical Standards
:
: The study was funded by Shire Development LLC. Writing and editing assistance for this paper was provided by Oxford PharmaGenesis, funded by Shire International GmbH. Shire International GmbH also funded open access.
: Caleb Bliss and Brigitte Robertson are employees of Shire and own stocks or stock options. The following authors have received compensation for serving as consultants or speakers for, or they or the institutions they work for have received research support or royalties from, the companies or organisations indicated: Tobias Banaschewski (Actelion, CIP Medien, Hexal Pharma, Hogrefe, Kohlhammer, Lilly, Lundbeck, Medice, Novartis, Oxford University Press, Shire and Vifor Pharma); David R. Coghill (Eli Lilly, Janssen-Cilag, Medice, Novartis, Oxford University Press, Shire and Vifor Pharma); Alessandro Zuddas (Angelini, EduPharma, Janssen, Lilly, Lundbeck, Oxford University Press, Roche, Servier and Shire).
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Each patient’s parent/legal guardian provided written informed consent, and assent was obtained from each participant (as applicable) before taking part in the study.